Back to search

Article

Enhanced Complement Expression in the Tumor Microenvironment Following Neoadjuvant Therapy: Implications for Immunomodulation and Survival in Pancreatic Ductal Adenocarcinoma

2023-10-30

Abstract excerpt

<h4>Purpose</h4> Neoadjuvant therapy (NAT) is increasingly being used for pancreatic ductal adenocarcinoma (PDAC) treatment. However, its distinct effects on carcinoma cells and the tumor microenvironment (TME) are not fully understood. This study employs spatial transcriptomics and single-cell RNA sequencing to investigate how NAT differentially remodels PDAC’s carcinoma cells and TME. <h4>Experimental Design</h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e1d5bd18-28ce-5b79-aed4-6eb393ee4965
DOI
10.1101/2023.10.26.564099
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enhanced Complement Expression in the Tumor Microenvironment Following Neoadjuvant Therapy: Implications for Immunomodulation and Survival in Pancreatic Ductal AdenocarcinomaDOI 10.1101/2023.10.26.564099
Select a neighboring publication to make it the new centre.